Just throwing this out there... Any possibility that NVS and MNTA would agree to change partnership terms for mL and mC? Essentially, MNTA offers to give up some share of its mC profitability to obtain better mL terms should another generic Lovenox is approved?
Market Data 
Markets 
AI
